DKI can distinguish high-grade gliomas from IDH1-mutant low-grade gliomas and correlate with their different nuclear-to-cytoplasm ratio: a localized biopsy-based study
- PMID: 37962597
- DOI: 10.1007/s00330-023-10325-8
DKI can distinguish high-grade gliomas from IDH1-mutant low-grade gliomas and correlate with their different nuclear-to-cytoplasm ratio: a localized biopsy-based study
Abstract
Objectives: To explore whether differences in diffusional kurtosis imaging (DKI) between therapy-naïve high-grade gliomas (HGGs) and low-grade gliomas (LGGs) are related to the cellularity and/or the nuclear-to-cytoplasmic (N/C) ratio.
Methods: We analyzed 44 and 40 diffuse glioma samples that were pathologically confirmed as HGGs and IDH1-mutant LGGs, respectively. The DKI parameters included kurtosis metrics (mean kurtosis [MK], axial kurtosis [K//], and radial kurtosis [K⊥]), and the diffusional metrics (fractional anisotropy [FA], mean diffusion [MD], axial diffusion [λ//], and radial diffusion [λ⊥]). The cellularity and the N/C ratio were compared within LGGs and HGGs using the Mann-Whitney U test (significant level, p < 0.007 [0.05/7]); Bonferroni correction). Spearman's correlation analysis was used to calculate the correlation coefficients among DKI metrics, cellularity, and the N/C ratio at a significant level of p = 0.05.
Results: Excluding FA, all DKI metrics showed significant differences between HGGs and LGGs (all p ≤ 0.001). The N/C ratio of HGGs was significantly higher than that of LGGs; however, differences in cellularity were not significant between the two glioma groups (p = 0.525). Similarly, excluding FA, all DKI metrics were significantly correlated with the N/C ratio in LGGs, with correlation coefficients of - 0.365 (MD), - 0.313 (λ//), - 0.376 (λ⊥), 0.859 (MK), 0.772 (K//), and 0.842 (K//). There was a non-significant correlation between any DKI parameters and the cellularity in LGGs. Additionally, the cellularity and N/C ratios in HGGs did not correlate with any DKI metrics.
Conclusions: DKI differentiate LGGs from HGGs associated with their different N/C ratios.
Clinical relevance statement: This study shows that DKI differentiates LGGs from HGGs may correlated with their different N/C ratios, this could provide a possible histopathological mechanism about why DKI can DKI differentiate LGGs from HGGs.
Key points: • Excluding FA, all DKI metrics showed a significant difference between high-grade gliomas and IDH1-mutant low-grade gliomas. • The nuclear-to-cytoplasm ratios in high-grade gliomas were significantly more extensive than that in IDH1-mutant low-grade gliomas, but not the cellularity. • Significant associations were seen between DKI measures and the N/C ratio; a non-significant correlation was noted between any DKI metric and cellularity in glioma specimens.
Keywords: Cellularity; Diffusional kurtosis imaging; High-grade gliomas; Low-grade gliomas; Nuclear-to-cytoplasmic ratio.
© 2023. The Author(s), under exclusive licence to European Society of Radiology.
Similar articles
-
Diffusion kurtosis imaging differs between primary central nervous system lymphoma and high-grade glioma and is correlated with the diverse nuclear-to-cytoplasmic ratio: a histopathologic, biopsy-based study.Eur Radiol. 2020 Apr;30(4):2125-2137. doi: 10.1007/s00330-019-06544-7. Epub 2019 Dec 19. Eur Radiol. 2020. PMID: 31858206
-
Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.J Neurooncol. 2019 Jan;141(1):195-203. doi: 10.1007/s11060-018-03025-7. Epub 2018 Nov 9. J Neurooncol. 2019. PMID: 30414095
-
Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.J Magn Reson Imaging. 2016 Jul;44(1):30-40. doi: 10.1002/jmri.25090. Epub 2015 Nov 20. J Magn Reson Imaging. 2016. PMID: 26588793
-
The diagnostic role of diffusional kurtosis imaging in glioma grading and differentiation of gliomas from other intra-axial brain tumours: a systematic review with critical appraisal and meta-analysis.Neuroradiology. 2020 Jul;62(7):791-802. doi: 10.1007/s00234-020-02425-9. Epub 2020 May 4. Neuroradiology. 2020. PMID: 32367349 Free PMC article.
-
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660. Neurosurg Focus. 2019. PMID: 31786548
Cited by
-
Research Progress on Glioma Microenvironment and Invasiveness Utilizing Advanced Multi-Parametric Quantitative MRI.Cancers (Basel). 2024 Dec 29;17(1):74. doi: 10.3390/cancers17010074. Cancers (Basel). 2024. PMID: 39796702 Free PMC article. Review.
-
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling.Cancer Biol Med. 2025 Feb 21;22(2):166-76. doi: 10.20892/j.issn.2095-3941.2024.0389. Cancer Biol Med. 2025. PMID: 39985133 Free PMC article.
-
Diffusion kurtosis imaging-based habitat analysis identifies high-risk molecular subtypes and heterogeneity matching in diffuse gliomas.Ann Clin Transl Neurol. 2024 Aug;11(8):2073-2087. doi: 10.1002/acn3.52128. Epub 2024 Jun 18. Ann Clin Transl Neurol. 2024. PMID: 38887966 Free PMC article.
-
Non-Invasive Diagnosis and Monitoring of Diabetic Nephropathy: Assessment of Renal Function and Fibrosis by Diffusion Kurtosis Imaging.Int J Gen Med. 2025 Jul 21;18:4011-4026. doi: 10.2147/IJGM.S517683. eCollection 2025. Int J Gen Med. 2025. PMID: 40717819 Free PMC article.
-
The value of morphological magnetic resonance imaging features combined with diffusion kurtosis imaging for predicting Ki-67 expression levels in high-grade gliomas.Quant Imaging Med Surg. 2025 Apr 1;15(4):2813-2826. doi: 10.21037/qims-24-2035. Epub 2025 Mar 21. Quant Imaging Med Surg. 2025. PMID: 40235755 Free PMC article.
References
-
- Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol 20:v1–v86 - DOI
-
- Central Brain Tumor Registry of the United States. http://www.cbtrus.org . Accessed February 12, 2012. Available
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous